March 17, 2017 / 8:33 PM / 6 months ago

BRIEF-Aveo Pharmaceuticals files for non-timely 10-K - SEC filing

March 17 (Reuters) - Aveo Pharmaceuticals Inc

* Files for non-timely 10-K - SEC filing

* Says identified a material weakness in its internal control over financial reporting.

* Aveo Pharmaceuticals - based on preliminary figures, expects to report net loss of $0.39 per basic and diluted share, for year ended December 31, 2016

* Aveo Pharmaceuticals - material weakness related to company's failure during 2016 to regularly reconcile U.K. bank account held by co's U.K. subsidiary Source text: (bit.ly/2mYehQD) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below